NSPR InspireMD, Inc.
Nasdaq · SEC CIK 1433607 · EDGAR
- Bought, last 12 months
- $518.0K 13 purchases by 4 insiders
- Sold, last 12 months
- $99.2K 1 sales by 1 insiders
- Filings on record
- 113 since 2021-08-26, latest 2026-09-23 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Stuka Paul | Dir | $283.9K | — |
| ROUBIN GARY S | Dir | $106.2K | — |
| Ward Scott R. | Dir | $102.6K | — |
| Gleason Shane Thomas | Chief Commercial Off | — | $99.2K |
| Slosman Marvin | CEO, Pres, Dir | $25.2K | — |
| Tommasoli Andrea | COO | — | — |
| Lawless Michael A | CFO | — | — |
| Arnold Kathryn | Dir | — | — |
| Dearen Danny L. | Dir | — | — |
| COHEN RAYMOND W | Dir | — | — |
Transactions 110
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 16:05 | 2026-05-27 | NSPR | Stuka Paul | Dir | P - Purchase | $0.875 | +20.0K | 667.9K | +3% | +$17.5K | |
| M | 2026-05-21 17:16 | 2025-01-27+ | NSPR | Gleason Shane Thomas | Chief Commercial Off | S - Sale | $2.22 | -85.3K | 1.05M | -7% | -$189.6K |
| M | 2026-05-15 16:05 | 2026-05-13+ | NSPR | Stuka Paul | Dir | P - Purchase | $1.16 | +15.0K | 647.9K | +2% | +$17.3K |
| 2026-05-13 17:00 | 2026-05-12 | NSPR | Slosman Marvin | CEO, Pres, Dir | P - Purchase | $1.20 | +21.0K | 3.56M | +0.6% | +$25.2K | |
| MA | 2026-05-13 16:47 | 2026-05-08+ | NSPR | Stuka Paul | Dir | P - Purchase | $1.16 | +75.6K | 632.9K | +14% | +$88.0K |
| MT | 2026-05-12 19:35 | 2026-05-08+ | NSPR | Stuka Paul | Dir | P - Purchase | $1.16 | +75.6K | 632.9K | +14% | +$88.0K |
| M | 2026-05-08 17:08 | 2026-05-06+ | NSPR | Ward Scott R. | Dir | P - Purchase | $1.15 | +89.2K | 237.1K | +60% | +$102.6K |
| M | 2026-05-08 17:05 | 2026-05-06+ | NSPR | Stuka Paul | Dir | P - Purchase | $1.14 | +7,895 | 531.6K | +2% | +$9,034 |
| 2026-05-08 17:03 | 2026-05-07 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $1.18 | +90.0K | 834.5K | +12% | +$106.2K | |
| A | 2026-02-23 | 2025-12-09 | NSPR | Stuka Paul | Dir | P - Purchase | $1.81 | +2,710 | 391.6K | +0.7% | +$4,905 |
| M | 2026-02-02 | 2026-01-15+ | NSPR | Gleason Shane Thomas | Chief Commercial Off | S - Sale | $1.62 | -61.2K | 1.15M | -5% | -$99.2K |
| 2026-01-16 | 2026-01-14 | NSPR | Dearen Danny L. | Dir | A - Grant | $0.00 | +44.0K | 102.0K | +76% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +453.4K | 1.20M | +61% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Lawless Michael A | CFO | A - Grant | $0.00 | +226.7K | 691.7K | +49% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Tommasoli Andrea | COO | A - Grant | $0.00 | +226.7K | 954.4K | +31% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +88.1K | 744.5K | +13% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +88.1K | 352.6K | +33% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +1.11M | 3.54M | +46% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Stuka Paul | Dir | A - Grant | $0.00 | +132.1K | 523.7K | +34% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | Ward Scott R. | Dir | A - Grant | $0.00 | +88.1K | 147.8K | +147% | $0 | |
| 2026-01-16 | 2026-01-14 | NSPR | COHEN RAYMOND W | Dir | A - Grant | $0.00 | +44.0K | 92.4K | +91% | $0 | |
| D | 2025-12-31 | 2025-12-30 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +55.6K | 303.1K | +22% | $0 |
| 2025-12-11 | 2025-12-09 | NSPR | Stuka Paul | Dir | P - Purchase | $1.81 | +5,073 | 391.6K | +1% | +$9,182 | |
| 2025-12-08 | 2025-12-05 | NSPR | Stuka Paul | Dir | P - Purchase | $1.86 | +5,073 | 388.9K | +1% | +$9,436 | |
| 2025-12-05 | 2025-12-04 | NSPR | Stuka Paul | Dir | P - Purchase | $1.85 | +10.1K | 383.8K | +3% | +$18.7K | |
| 2025-11-13 | 2025-11-12 | NSPR | Stuka Paul | Dir | P - Purchase | $1.62 | +13.4K | 373.7K | +4% | +$21.8K | |
| 2025-10-09 | 2025-10-07 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +48.0K | 656.4K | +8% | $0 | |
| D | 2025-09-17 | 2025-09-15 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +37.8K | 458.6K | +9% | $0 |
| 2025-08-01 | 2025-07-30 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $2.42 | +41.3K | 608.4K | +7% | +$100.0K | |
| 2025-08-01 | 2025-07-30 | NSPR | Kester Thomas J | Dir | P - Purchase | $2.42 | +31.0K | 420.8K | +8% | +$75.0K | |
| I | 2025-08-01 | 2025-07-30 | NSPR | Stuka Paul | Dir | P - Purchase | $2.42 | +20.7K | 444.2K | +5% | +$50.0K |
| 2025-08-01 | 2025-07-30 | NSPR | Slosman Marvin | CEO, Pres, Dir | P - Purchase | $2.42 | +10.3K | 2.42M | +0.4% | +$25.0K | |
| DI | 2025-07-23 | 2025-07-01 | NSPR | Stuka Paul | Dir | X - OptEx | $1.38 | +87.5K | 423.5K | +26% | +$120.7K |
| D | 2025-07-23 | 2025-07-11 | NSPR | Kester Thomas J | Dir | X - OptEx | $1.38 | +30.6K | 389.8K | +9% | +$42.3K |
| D | 2025-07-23 | 2025-06-25 | NSPR | ROUBIN GARY S | Dir | X - OptEx | $1.38 | +30.6K | 567.1K | +6% | +$42.3K |
| DI | 2025-07-23 | 2025-06-29 | NSPR | BERMAN MICHAEL | Dir | X - OptEx | $1.38 | +61.2K | 245.0K | +33% | +$84.5K |
| D | 2025-01-10 | 2025-01-07 | NSPR | Tommasoli Andrea | COO | A - Grant | $0.00 | +232.6K | 727.7K | +47% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Ward Scott R. | Dir | A - Grant | $0.00 | +16.2K | 59.8K | +37% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Verta Patrick | EVP Clinical, Medical Affairs | A - Grant | $0.00 | +83.1K | 311.5K | +36% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +32.5K | 247.5K | +15% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +32.5K | 264.5K | +14% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +32.5K | 534.3K | +6% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +558.4K | 2.41M | +30% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Stuka Paul | Dir | A - Grant | $0.00 | +48.7K | 360.3K | +16% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +32.5K | 359.1K | +10% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +232.6K | 1.11M | +26% | $0 |
| D | 2025-01-10 | 2025-01-07 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +232.6K | 747.0K | +45% | $0 |
| DI | 2024-06-26 | 2024-06-24 | NSPR | BERMAN MICHAEL | Dir | X - OptEx | $1.38 | +61.2K | 183.7K | +50% | +$84.5K |
| D | 2024-06-25 | 2024-05-28 | NSPR | Kester Thomas J | Dir | X - OptEx | $1.38 | +30.6K | 326.7K | +10% | +$42.3K |
| DI | 2024-06-07 | 2024-06-05 | NSPR | Stuka Paul | Dir | X - OptEx | $1.38 | +87.5K | 336.0K | +35% | +$120.7K |
| D | 2024-05-30 | 2024-05-28 | NSPR | ROUBIN GARY S | Dir | X - OptEx | $1.38 | +30.6K | 501.8K | +6% | +$42.3K |
| D | 2024-01-25 | 2024-01-23 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +238.6K | 514.4K | +87% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +29.0K | 296.1K | +11% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Stuka Paul | Dir | A - Grant | $0.00 | +43.5K | 311.5K | +16% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Verta Patrick | EVP Clinical, Medical Affairs | A - Grant | $0.00 | +85.7K | 228.5K | +60% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +238.6K | 879.8K | +37% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +29.0K | 471.2K | +7% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +29.0K | 215.0K | +16% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +29.0K | 232.0K | +14% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +563.5K | 1.85M | +44% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Tommasoli Andrea | COO | A - Grant | $0.00 | +238.6K | 495.1K | +93% | $0 |
| 2024-01-11 | 2024-01-02 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +3,229 | 442.1K | +0.7% | $0 | |
| 2024-01-11 | 2024-01-02 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +1,661 | 186.0K | +0.9% | $0 | |
| 2024-01-11 | 2024-01-02 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +3,782 | 203.0K | +2% | $0 | |
| 2024-01-11 | 2024-01-02 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +3,183 | 267.0K | +1% | $0 | |
| 2023-12-04 | 2023-11-30 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $2.53 | +50.0K | 438.9K | +13% | +$126.5K | |
| 2023-10-04 | 2023-10-02 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +3,106 | 199.2K | +2% | $0 | |
| 2023-10-04 | 2023-10-02 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +1,364 | 184.3K | +0.7% | $0 | |
| 2023-10-04 | 2023-10-02 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +2,652 | 388.9K | +0.7% | $0 | |
| 2023-10-04 | 2023-10-02 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +2,614 | 263.9K | +1% | $0 | |
| D | 2023-08-30 | 2023-08-28 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +19.3K | 275.7K | +8% | $0 |
| 2023-07-05 | 2023-07-01 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +1,772 | 183.0K | +1.0% | $0 | |
| 2023-07-05 | 2023-07-01 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +3,396 | 261.2K | +1% | $0 | |
| 2023-07-05 | 2023-07-01 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +3,445 | 386.2K | +0.9% | $0 | |
| 2023-07-05 | 2023-07-01 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +4,351 | 196.1K | +2% | $0 | |
| D | 2023-05-19 | 2023-05-17 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +149.3K | 257.9K | +137% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +149.3K | 192.1K | +349% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Gleason Shane Thomas | VP Gbl Marketing | A - Grant | $0.00 | +256.4K | 256.4K | New | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +149.3K | 382.8K | +64% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Tommasoli Andrea | COO | A - Grant | $0.00 | +179.1K | 256.5K | +231% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Stuka Paul | Dir | A - Grant | $0.00 | +225.7K | 268.0K | +533% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +522.6K | 641.2K | +440% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +1.05M | 1.29M | +429% | $0 |
| D | 2023-05-19 | 2023-05-17 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +149.3K | 181.2K | +467% | $0 |
| D | 2023-05-16 | 2023-05-12 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $1.63 | +61.2K | 233.5K | +36% | +$99.8K |
| DI | 2023-05-16 | 2023-05-12 | NSPR | Stuka Paul | Dir | P - Purchase | $1.63 | +175.0K | 248.5K | +238% | +$285.2K |
| D | 2023-05-16 | 2023-05-12 | NSPR | Kester Thomas J | Dir | P - Purchase | $1.63 | +61.2K | 108.6K | +129% | +$99.8K |
| DI | 2023-05-16 | 2023-05-12 | NSPR | BERMAN MICHAEL | Dir | P - Purchase | $1.63 | +122.5K | 122.5K | New | +$199.7K |
| 2023-04-04 | 2023-04-01 | NSPR | Arnold Kathryn | Dir | A - Grant | $0.00 | +4,167 | 32.0K | +15% | $0 | |
| 2023-04-04 | 2023-04-01 | NSPR | ROUBIN GARY S | Dir | A - Grant | $0.00 | +8,102 | 172.3K | +5% | $0 | |
| 2023-04-04 | 2023-04-01 | NSPR | BERMAN MICHAEL | Dir | A - Grant | $0.00 | +9,491 | 42.8K | +28% | $0 | |
| 2023-04-04 | 2023-04-01 | NSPR | Kester Thomas J | Dir | A - Grant | $0.00 | +7,986 | 47.3K | +20% | $0 | |
| 2022-08-22 | 2022-08-18 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $1.91 | +35.5K | 164.2K | +28% | +$67.8K | |
| DA | 2022-01-06 | 2021-11-10 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +73.0K | 118.6K | +160% | $0 |
| 2021-12-30 | 2021-12-28 | NSPR | ROUBIN GARY S | Dir | P - Purchase | $3.08 | +16.4K | 128.7K | +15% | +$50.5K | |
| I | 2021-12-02 | 2021-12-01 | NSPR | Stuka Paul | Dir | P - Purchase | $3.51 | +12.0K | 73.5K | +20% | +$42.2K |
| MI | 2021-11-30 | 2021-11-29+ | NSPR | Stuka Paul | Dir | P - Purchase | $3.55 | +21.5K | 43.1K | +100% | +$76.5K |
| I | 2021-11-29 | 2021-11-26 | NSPR | Stuka Paul | Dir | P - Purchase | $3.55 | +1,200 | 39.9K | +3% | +$4,260 |
| I | 2021-11-26 | 2021-11-24 | NSPR | Stuka Paul | Dir | P - Purchase | $3.55 | +18.3K | 38.7K | +90% | +$65.1K |
| MI | 2021-11-23 | 2021-11-22+ | NSPR | Stuka Paul | Dir | P - Purchase | $3.54 | +20.4K | 20.4K | +72,829% | +$72.2K |
Purchase Sale Sale after option exercise All abbreviations